Literature DB >> 9217176

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

G D Lowe1, A Rumley, M Woodward, C E Morrison, H Philippou, D A Lane, H Tunstall-Pedoe.   

Abstract

Coagulation factor activity (fibrinogen, VII, VIII and IX), coagulation inhibitor activity (antithrombin, protein C, protein S), and coagulation activation markers (prothrombin fragment F1, 2; thrombin-antithrombin complexes) were measured in 747 men and 817 women aged 25-74 years, randomly sampled from the north Glasgow population in the Third MONICA Survey. Significant effects of age, sex, menopause and hormone use were observed and specific reference ranges are presented to illustrate these effects. Significant correlations were observed between several coagulation factors and inhibitors. Increased levels of factors VII, VIII and IX and decreased levels of protein C were associated with increased coagulation activation. In general, increases in coagulation factors with age were greater than increases in coagulation inhibitors, especially in men; this imbalance may favour increased coagulation activation and hence increased thrombotic risk with age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217176     DOI: 10.1046/j.1365-2141.1997.1222936.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  37 in total

Review 1.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

2.  Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).

Authors:  Shaheeda Ahmed; Elliott M Antman; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Harvey White; David A Morrow; Eugene Braunwald
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

3.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

4.  Factor IX and deep vein thrombosis.

Authors:  Gordon Lowe
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

5.  An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.

Authors:  Sumiko Kurachi; Jeffrey S Huo; Afshin Ameri; Kezhong Zhang; Akiyasu C Yoshizawa; Kotoku Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

6.  Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy.

Authors:  Meng-jie Huang; Ri-bao Wei; Qing-ping Li; Xi Yang; Cui-ming Cao; Ting-yu Su; Na Wang; Rui Wang; Xiang-mei Chen
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

7.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

8.  Reference values for kaolin-activated thromboelastography in volunteers of Anhui Province in China.

Authors:  Jun-Bo Sun; Mao-Hong Bian; Tao Zhong; Ying-Yu Lu; Bang-Qiang Zhu; Hui-Qin Wen; Hai-Liang Hu
Journal:  J Clin Lab Anal       Date:  2017-01-30       Impact factor: 2.352

9.  The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.

Authors:  J Michael Soucie; Paul E Monahan; Roshni Kulkarni; Barbara A Konkle; Marshall A Mazepa
Journal:  Blood Adv       Date:  2018-08-28

10.  Hemostasis and ageing.

Authors:  Daniela Mari; Giulia Ogliari; Davide Castaldi; Giovanni Vitale; Elisa Mariadele Bollini; Domenico Lio
Journal:  Immun Ageing       Date:  2008-10-23       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.